Back to Archived Journals » Oncolytic Virotherapy » Volume 2
Oncolytic Virotherapy ceased publishing in January 2023. All articles that have been published in Oncolytic Virotherapy will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
![](https://www.dovepress.com/cr_data/cache/journal_image/141/cope/thumb_100_1000_100.jpg)
Oncolytic Virotherapy
ISSN: 2253-1572
- View all (70)
- Volume 10, 2021 (1)
- Volume 9, 2020 (2)
- Volume 8, 2019 (6)
- Volume 7, 2018 (11)
- Volume 6, 2017 (6)
- Volume 5, 2016 (10)
- Volume 4, 2015 (20)
- Volume 3, 2014 (8)
- Volume 2, 2013 (5)
- Volume 1, 2012 (1)
Archive: Volume 2, 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Oncolytic herpes viruses, chemotherapeutics, and other cancer drugs
Braidwood L, Graham SV, Graham A, Conner J
Oncolytic Virotherapy 2013, 2:57-74
Published Date: 6 December 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Cell carriers for oncolytic viruses: current challenges and future directions
Roy DG, Bell JC
Oncolytic Virotherapy 2013, 2:47-56
Published Date: 10 October 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Oncolytic virus therapy for cancer
Goldufsky J, Sivendran S, Harcharik S, Pan M, Bernardo S, Stern RH, Friedlander P, Ruby CE, Saenger Y, Kaufman HL
Oncolytic Virotherapy 2013, 2:31-46
Published Date: 24 September 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Oncolytic virotherapy: the questions and the promise
Aurelian L
Oncolytic Virotherapy 2013, 2:19-29
Published Date: 4 June 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Histological evaluation of intratumoral myxoma virus treatment in an immunocompetent mouse model of melanoma
Doty RA, Liu J, McFadden G, Roy EJ, MacNeill AL
Oncolytic Virotherapy 2013, 2:1-17
Published Date: 14 January 2013